KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Free Cash Flow (2016 - 2025)

Rigel Pharmaceuticals has reported Free Cash Flow over the past 16 years, most recently at $22.0 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 51.91% year-over-year to $22.0 million; the TTM value through Dec 2025 reached $75.7 million, up 140.63%, while the annual FY2025 figure was $75.7 million, 140.67% up from the prior year.
  • Free Cash Flow for Q4 2025 was $22.0 million at Rigel Pharmaceuticals, down from $24.0 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $54.8 million in Q2 2021 and troughed at -$25.9 million in Q1 2022.
  • A 5-year average of $1.6 million and a median of -$2.7 million in 2023 define the central range for Free Cash Flow.
  • Biggest five-year swings in Free Cash Flow: crashed 441.24% in 2021 and later soared 10011.59% in 2025.
  • Year by year, Free Cash Flow stood at -$19.1 million in 2021, then fell by 15.3% to -$22.0 million in 2022, then surged by 71.61% to -$6.2 million in 2023, then surged by 332.0% to $14.5 million in 2024, then skyrocketed by 51.91% to $22.0 million in 2025.
  • Business Quant data shows Free Cash Flow for RIGL at $22.0 million in Q4 2025, $24.0 million in Q3 2025, and $30.5 million in Q2 2025.